Allopurinol in Gout Management

Role of Allopurinol

The American College of Physicians recommends allopurinol as a urate-lowering therapy (ULT) for long-term gout management, not acute flare treatment, which reduces serum uric acid levels over weeks to months, preventing future gout attacks with moderate-quality evidence 1, 2, 3
Allopurinol reduces serum uric acid levels, which prevents future gout attacks but does not resolve acute inflammation, by inhibiting xanthine oxidase to decrease uric acid production 1, 4
Long-term therapy (>1 year) with allopurinol reduces gout flares with moderate-quality evidence 2, 3

The American College of Rheumatology recommends using anti-inflammatory medications such as NSAIDs, colchicine, or corticosteroids for acute gout attacks, which address the inflammatory process causing pain and swelling in acute flares 1, 4
High-strength evidence supports colchicine, NSAIDs, and corticosteroids for symptom relief during acute attacks 4

The European League Against Rheumatism (EULAR) guidelines suggest that starting allopurinol during an acute attack may be safe if anti-inflammatory therapy is provided concurrently, although traditional approaches recommend delaying initiation until after flare resolution 5
Historically, allopurinol initiation was delayed 2 weeks after flare resolution to avoid prolonging or worsening the attack 5

For a patient presenting with acute gout flare, the American College of Physicians recommends treating the acute flare first with NSAIDs, colchicine, or corticosteroids, and then assessing indications for long-term ULT 1, 4, 5
The American College of Physicians also recommends mandatory anti-inflammatory prophylaxis, such as low-dose colchicine or NSAIDs, for at least 6 months when starting ULT 1, 2

Asian patients (Han Chinese, Thai, Korean) with CKD stage ≥3 should be tested for HLA-B*5801 before starting allopurinol due to increased risk of fatal hypersensitivity reactions, as recommended by the American College of Physicians 2, 3

The American College of Physicians suggests that allopurinol can be safely started during an acute gout attack if the patient is simultaneously treated with anti-inflammatory medications, with the goal of reducing serum uric acid levels to <360 μmol/L (6 mg/dL) 6, 7

The European League Against Rheumatism (EULAR) guidelines recommend starting allopurinol at a low dose (100 mg daily) and increasing by 100 mg every 2-4 weeks as needed, with mandatory anti-inflammatory prophylaxis with low-dose colchicine (0.5-1 mg daily) or NSAIDs for at least 6 months 7, 8, 6

The American College of Physicians recommends starting allopurinol in patients with recurrent acute attacks (≥2 per year), presence of tophi, chronic gouty arthropathy or radiographic changes, or chronic kidney disease 7, 6

The American College of Physicians suggests adjusting the allopurinol dose in renal impairment, as it requires dose reduction with declining kidney function, and stopping diuretics if possible when gout is associated with diuretic use 7, 8, 6

The European League Against Rheumatism (EULAR) guidelines recommend treating the acute flare immediately with NSAIDs, colchicine, or corticosteroids, and assessing if the patient meets criteria for long-term urate-lowering therapy, with the option to start allopurinol 100 mg daily during the acute attack while continuing anti-inflammatory treatment 7, 6, 9

High-strength evidence shows urate-lowering therapy does not reduce acute attacks in the first 6 months, but moderate-strength evidence demonstrates it reduces flares after approximately 1 year of continuous therapy, according to the Annals of Internal Medicine 10
The American College of Rheumatology conditionally recommends starting allopurinol during an acute flare if anti-inflammatory therapy is provided concurrently, as supported by two small randomized trials 11
EULAR guidelines note that initiating allopurinol at 100-300 mg during acute attacks did not prolong flare duration or worsen severity when patients received concurrent anti-inflammatory treatment, although these trials were underpowered 11
High-quality evidence from the CONFIRMS trial showed that continuing prophylaxis for 6 months prevented the spike in flares seen after early discontinuation, as reported in the Annals of Internal Medicine 10

Start allopurinol at 100 mg daily and increase by 100 mg every 2-4 weeks until serum uric acid <6 mg/dL, with mandatory anti-inflammatory prophylaxis with colchicine 0.5-1 mg daily or low-dose NSAIDs for at least 6 months, as recommended by the Annals of the Rheumatic Diseases 11
Target serum uric acid <6 mg/dL for most patients, or <5 mg/dL for severe gout with tophi, and adjust dose in renal impairment, according to the Annals of the Rheumatic Diseases 11
Colchicine prophylaxis dose must be reduced in renal impairment and with concurrent statin use due to neurotoxicity/muscular toxicity risk, as noted in the Annals of the Rheumatic Diseases 11